The HTA review remains shrouded in secrecy, with brief and vaguely worded agendas released after meetings are held, no communiqués published for the past seven meetings, and organisations in other countries knowing more about the options under consideration and seeming to have more input than the Australian community.
But for a few selected insiders, the HTA review is a 'bin fire' of non-transparency
September 11, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
New partnership promotes buy local for homegrown innovation
May 8, 2025 - - Latest News -
New Zealand to change laws to promote medical conferences
May 8, 2025 - - Latest News -
Australia is about to get a new industry minister
May 8, 2025 - - Latest News -
Internal promotions for new generation of leaders at Astellas
May 7, 2025 - - Latest News -
New study reveals the far-reaching impact of ovarian cancer
May 7, 2025 - - Latest News -
Just the threat of tariffs has secured a quarter of a trillion in investment
May 7, 2025 - - Latest News -
Percheron Therapeutics launches bonus loyalty option offer
May 7, 2025 - - Australian Biotech